Physician profile
Ethan Kellum
NPI 1396907705
$6,669.81
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $674 · 2020: $3,503 · 2021: $1,972 · 2022: $382 · 2024: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $138.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,648.08 | 2020-2021 | |
| Alpha Orthopedic Systems | $1,495.23 | 2019-2021 | |
| Organogenesis INC. | $416.75 | 2020-2022 | |
| Electronic Waveform Lab, INC. | $372.56 | 2019-2020 | |
| Bioventus LLC | $252.00 | 2019-2021 | |
| Triad Life Sciences INC. | $146.89 | 2022 | |
| Onkos Surgical, INC. | $125.33 | 2024 | Eleos Limb Salvage System |
| Fidia Pharma USA INC. | $111.27 | 2019-2022 | |
| Uoc USA INC | $48.66 | 2019 | |
| Allergan, INC. | $16.35 | 2021 | |
| Abbvie INC. | $13.10 | 2024 | |
| Glaxosmithkline, LLC. | $12.56 | 2019 | |
| Orthogenrx INC. | $11.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ethan Kellum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.